Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9893070 | 0.84 | MAPK14 (0.47) | MAPK14ADORA2BRPS6KA2RAB9AHPGD | |
| SCHEMBL11738978 | 0.80 | MAPK14 (0.44) | MAPK14ADORA2BRPS6KA2RAB9AHPGD | |
| SCHEMBL9892349 | 0.80 | MAPK14 (0.44) | MAPK14ADORA2BRPS6KA2RAB9AHPGD | |
| SCHEMBL9891916 | 0.80 | MAPK14 (0.57) | MAPK14RAB9AALDH1A1LMNATSHR | |
| SCHEMBL9891810 | 0.75 | ALDH1A1 (0.50) | MAPK14ADORA2BRAB9AALDH1A1LMNA | |
| SCHEMBL15000477 | 0.75 | ALDH1A1 (0.60) | ADORA2BRAB9AALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL9713191 | 0.75 | MAPK14 (0.48) | MAPK14ADORA2BRPS6KA2RAB9AALDH1A1 | |
| SCHEMBL9891811 | 0.73 | ALDH1A1 (0.64) | MAPK14RPS6KA2RAB9AALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL28560605 | 0.73 | MAPK14 (0.39) | MAPK14ADORA2BRPS6KA2RAB9AHPGD | |
| SCHEMBL16542496 | 0.72 | MAPK14 (0.37) | MAPK14ADORA2BRPS6KA2RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629157-B2 | Pyrrolidine compounds which modulate the CB2 receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | CNR2, CNR1, OPRL1 | MAPK14 1949/4885ADORA2B 130/4885RPS6KA2 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.